60

FUREN Group Pharmaceutical Co LtdSHG 600781 Stock Report

Last reporting period 31 Dec, 2022

Updated —

Last price

Market cap $B

0.069

Micro

Exchange

XSHG - Shanghai Stock Exchange

600781.SS Stock Analysis

60

Uncovered

FUREN Group Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-58/100

Low score

Market cap $B

0.069

Dividend yield

Shares outstanding

627.16 B

Website

FUREN Group Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Zhengzhou, Henan and currently employs 2,916 full-time employees. The firm's principal business is the manufacture of proprietary Chinese medicines, including capsules, tablets, granules, gels, injections, suspensions, drops, syrups and others. The firm mainly distributes its products in the domestic market.

View Section: Eyestock Rating